# Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults

> **NCT07162649** · NA · WITHDRAWN · sponsor: **Tongji University**

## Conditions studied

- Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07162649
- **Lead sponsor:** Tongji University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-01
- **Primary completion:** 2027-08-30
- **Final completion:** 2028-08-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was terminated due to a strategic prioritization and realignment of the research and development portfolio by the study team.
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162649, "Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07162649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*